Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Effectiveness and safety as outcome measures in reproductive medicine.

Braakhekke M, Kamphuis EI, Mol F, Norman RJ, Bhattacharya S, van der Veen F, Mol BW.

Hum Reprod. 2015 Oct;30(10):2249-51. doi: 10.1093/humrep/dev201.

PMID:
26384402
2.

Fetal Gender of the First Born and the Recurrent Risk of Spontaneous Preterm Birth.

Kamphuis EI, Koullali B, Hof M, de Groot CJ, Kazemier BM, Robertson S, Mol BW, Ravelli AC.

Am J Perinatol. 2015 Dec;32(14):1305-10. doi: 10.1055/s-0035-1563716. Epub 2015 Sep 9.

PMID:
26352684
3.

The risk of preterm birth of treated versus untreated cervical intraepithelial neoplasia (CIN): a systematic review and meta-analysis.

Danhof NA, Kamphuis EI, Limpens J, van Lonkhuijzen LR, Pajkrt E, Mol BW.

Eur J Obstet Gynecol Reprod Biol. 2015 May;188:24-33. doi: 10.1016/j.ejogrb.2015.02.033. Epub 2015 Mar 2. Review.

PMID:
25770844
4.

Should the individual preterm birth risk be incorporated into the embryo transfer policy in in vitro fertilisation? A decision analysis.

Kamphuis EI, van Wely M, Repping S, van der Veen F, de Groot CJ, Hompes P, Mol BW, Kazemier BM.

BJOG. 2015 May;122(6):825-33. doi: 10.1111/1471-0528.12980. Epub 2014 Jul 16.

5.

Loop electrosurgical excision procedure and risk of preterm birth.

Danhof N, Kamphuis E, Mol B.

Obstet Gynecol. 2014 Jul;124(1):163. doi: 10.1097/AOG.0000000000000353. No abstract available.

PMID:
24945447
6.

Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper.

Braakhekke M, Kamphuis EI, Dancet EA, Mol F, van der Veen F, Mol BW.

Fertil Steril. 2014 May;101(5):1203-4. doi: 10.1016/j.fertnstert.2014.03.047. Review.

PMID:
24786739
7.

How are neonatal and maternal outcomes reported in randomised controlled trials (RCTs) in reproductive medicine?

Braakhekke M, Kamphuis EI, van Rumste MM, Mol F, van der Veen F, Mol BW.

Hum Reprod. 2014 Jun;29(6):1211-7. doi: 10.1093/humrep/deu069. Epub 2014 Apr 7.

8.

Changes in risk factors for preterm birth in Western Australia 1984-2006.

Hermans FJ, Kamphuis EI, Mol BW.

BJOG. 2013 Dec;120(13):1698. doi: 10.1111/1471-0528.12410. No abstract available.

9.

Are we overusing IVF?

Kamphuis EI, Bhattacharya S, van der Veen F, Mol BW, Templeton A; Evidence Based IVF Group.

BMJ. 2014 Jan 28;348:g252. doi: 10.1136/bmj.g252. Review. No abstract available.

PMID:
24472708
10.

Legislation of embryo transfer affected the denominator, not the numerator!

Scholten I, Kamphuis E, Mol BW.

Hum Reprod. 2014 Feb;29(2):381. doi: 10.1093/humrep/det415. Epub 2013 Nov 25. No abstract available.

11.

A multi-dose serological assay suitable to quantify the potency of inactivated rabies vaccines for veterinary use.

Krämer B, Kamphuis E, Hanschmann KM, Milne C, Daas A, Duchow K.

Biologicals. 2013 Nov;41(6):400-6. doi: 10.1016/j.biologicals.2013.08.003. Epub 2013 Oct 18.

PMID:
24144483
12.

Tubal factor infertility and perinatal risk after assisted reproductive technology.

Kamphuis EI, Hermans FJ, Mol BW.

Obstet Gynecol. 2013 Oct;122(4):908. doi: 10.1097/AOG.0b013e3182a7c1f6. No abstract available.

PMID:
24084559
13.

Potency estimation of vaccine batches remains unaffected by anesthesia for intracerebral injection.

Kamphuis E, Hanschmann KM, Meyer H, Göpfert C, Krämer B, Cussler K.

Biologicals. 2012 Nov;40(6):451-5. doi: 10.1016/j.biologicals.2012.07.014. Epub 2012 Oct 13.

PMID:
23068315
14.

Potency testing of inactivated rabies vaccines using a serological method.

Kamphuis E, Krämer B, Schildger H, Duchow K.

Dev Biol (Basel). 2012;134:23-7.

PMID:
22888591
15.

Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward.

Stokes W, McFarland R, Kulpa-Eddy J, Gatewood D, Levis R, Halder M, Pulle G, Kojima H, Casey W, Gaydamaka A, Miller T, Brown K, Lewis C, Chapsal JM, Bruckner L, Gairola S, Kamphuis E, Rupprecht CE, Wunderli P, McElhinney L, De Mattia F, Gamoh K, Hill R, Reed D, Doelling V, Johnson N, Allen D, Rinckel L, Jones B.

Biologicals. 2012 Sep;40(5):369-81. doi: 10.1016/j.biologicals.2012.07.005. Epub 2012 Aug 11.

PMID:
22884673
16.

Vaccination against Feline Panleukopenia: implications from a field study in kittens.

Jakel V, Cussler K, Hanschmann KM, Truyen U, König M, Kamphuis E, Duchow K.

BMC Vet Res. 2012 May 21;8:62. doi: 10.1186/1746-6148-8-62.

17.

Potency testing of veterinary vaccines: the way from in vivo to in vitro.

Romberg J, Lang S, Balks E, Kamphuis E, Duchow K, Loos D, Rau H, Motitschke A, Jungbäck C.

Biologicals. 2012 Jan;40(1):100-6. doi: 10.1016/j.biologicals.2011.10.004. Epub 2011 Nov 9.

PMID:
22075457
18.

The effects of spinal anesthesia with lidocaine and sufentanil on lower urinary tract functions.

Kamphuis ET, Kuipers PW, van Venrooij GE, Kalkman CJ.

Anesth Analg. 2008 Dec;107(6):2073-8. doi: 10.1213/ane.0b013e318187bc0e.

PMID:
19020161
19.
20.

Type I interferons directly regulate lymphocyte recirculation and cause transient blood lymphopenia.

Kamphuis E, Junt T, Waibler Z, Forster R, Kalinke U.

Blood. 2006 Nov 15;108(10):3253-61. Epub 2006 Jul 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk